Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company focused on the development of a broad portfolio of oncology drug candidates for the treatment of highly resistant tumors.

Biotechnology

Pharmaceutical

Moleculin

Moleculin's headquarters in Houston, TX, United States

Walter Klemp

Donald Picker

Jonathan P. Foster

Cynthia Abbate

Robert Shepard

Robert E. George

John Climaco

Martin Tallman

Hongbo Zhai

Elizabeth Cermak

Dominique Schols

Waldemar Priebe

James L. Abbruzzese

Richard Whitley

Michael D. Cannon

Jorge Cortes

The Scientific Advisors at Moleculin play a crucial role in guiding the development of oncology drug candidates by providing expert insights and recommendations on research strategies, clinical trial designs, and regulatory pathways. With a diverse background in oncology, they collaborate with the leadership team to ensure that the scientific approach aligns with industry standards and addresses the complex challenges of treating highly resistant tumors. Their expertise helps to enhance the efficacy and safety profile of Moleculin’s innovative therapies.

Scientific Advisors

The Leadership Team at Moleculin drives the strategic direction and operational effectiveness of the company, focusing on the advancement of innovative oncology drug candidates. Comprised of executive leaders in scientific, financial, and medical domains, the team collaborates to ensure successful clinical development, regulatory compliance, and market readiness, ultimately aiming to improve treatment options for patients with highly resistant tumors.

Leadership Team

The Clinical Development Team at Moleculin is responsible for designing and executing clinical trials for the company's oncology drug candidates. This team collaborates closely with regulatory bodies to ensure compliance and oversees the development process from concept through Phase I-III trials. Their goal is to generate robust clinical data that supports the safety and efficacy of treatments targeting highly resistant tumors.

Clinical Development Team

The Finance Team at Moleculin is responsible for managing the company's financial planning and analysis, ensuring fiscal discipline, and overseeing accounting operations. They provide strategic financial insights to support the development of oncology drug candidates, facilitate budget management, and ensure compliance with regulatory requirements, ultimately aiding in the company's mission to combat highly resistant tumors.

Moleculin

Org chart

Board & advisors

Teams

Scientific Advisors

Leadership Team

Clinical Development Team

Finance Team

Offices

Moleculin

Org chart

Board & advisors

Teams

Scientific Advisors

Leadership Team

Clinical Development Team

Finance Team

Offices

Related companies